Revenue for the first quarter of 2025 was $17.5 million, a decrease of 9$17.1 million, a decrease of 6% compared to the same • Generated first quarter 2025 total revenue of $17.5 million, a decrease of 9% compared to the same period in the prior year. This decline was primarily due to lower revenue from the Company's Surgical Glaucoma segment, which decreased 6% compared to the same period in the prior year. The expected decrease ...